Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
A1-Cal D3 500mg/400unit chewable tablets sugar free
0906040G0ELAAFI
|
A1-Cal D3 | Colecalciferol | Nutrition and Blood | 80 |
|
A1-Cal D3 Max 600mg/400unit chewable tablets sugar free
0906040G0ELABFJ
|
A1-Cal D3 | Colecalciferol | Nutrition and Blood | 25 |
|
A1-Cal D3 500mg/400unit chewable tablets
0906040G0ELACBW
|
A1-Cal D3 | Colecalciferol | Nutrition and Blood | No data available |
|
A1-Cal D3 Max 600mg/400unit chewable tablets
0906040G0ELADBY
|
A1-Cal D3 | Colecalciferol | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.